This mechanism mediates DLGAP1-AS2-dependent oncogenesis and NSCLC progression, stimulation of c-Myc-dependent aerobic glycolysis, and deteriorated prognosis of patients (Table 4). The gene discussed is MYC; the disease is non-small cell lung carcinoma.